The health benefits promised by cell and gene therapy will likely be delayed if increased numbers of young investigators are not recruited into the field. This proposal from the Center for Cell and Gene Therapy (CAGT) / Baylor College of Medicine seeks to establish a training program for both predoctoral students and postdoctoral fellows with career research interests in cell and gene therapy - either its fundamental or clinical aspects, or both. The rationale is that a stimulating program of education and laboratory training will attract promising candidates, including under-represented minorities, to this emerging field and increase the likelihood of their pursuing careers as members of translational research teams. The proposed training takes advantage of the outstanding biomedical curricula and experienced faculty within the Baylor system and the CAGT. A cadre of 24 faculty members with research interests in vector design and targeting, stem cell biology, molecular and cellular genetics, immunotherapy, gene therapy and stem cell transplantation, among other topics, will be available to mentor successful candidates (three [3] predoctoral students and three [3] postdoctoral fellows at any given time). Major strengths of the program are (1) its targeting of rigorous basic biomedical science and clinical research training toward a translational goal; (2) its strong reliance on the proven scientific excellence of cell biology and genetics research training programs at Baylor, and (3) its involvement of mentors, including the program director and co-directors, who have a wealth of experience in translational research and in training young investigators. Augmenting the formal course work and laboratory training will be opportunities to present recent research findings at annual retreats sponsored by the CAGT and academic departments within Baylor. Taken together, these program elements especially the mentored laboratory research experience, should provide trainees with a strong foundation for translational research careers in cell and gene therapy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK064717-04
Application #
7095842
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Bishop, Terry Rogers
Project Start
2003-07-01
Project End
2008-06-30
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
4
Fiscal Year
2006
Total Cost
$155,287
Indirect Cost
Name
Baylor College of Medicine
Department
Pediatrics
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Rouce, Rayne H; Sharma, Sandhya; Huynh, Mai et al. (2017) Recent advances in T-cell immunotherapy for haematological malignancies. Br J Haematol 176:688-704
Akinfenwa, Patricia Y; Bond, Wesley S; Ildefonso, Cristhian J et al. (2017) Versican G1 domain enhances adenoviral-mediated transgene expression and can be modulated by inhibitors of the Janus kinase (JAK)/STAT and Src family kinase pathways. J Biol Chem 292:14381-14390
Lee, Hyun Kyoung; Laug, Dylan; Zhu, Wenyi et al. (2015) Apcdd1 stimulates oligodendrocyte differentiation after white matter injury. Glia 63:1840-9
Mata, Melinda; Vera, Juan F; Gerken, Claudia et al. (2014) Toward immunotherapy with redirected T cells in a large animal model: ex vivo activation, expansion, and genetic modification of canine T cells. J Immunother 37:407-15
Dotti, Gianpietro; Gottschalk, Stephen; Savoldo, Barbara et al. (2014) Design and development of therapies using chimeric antigen receptor-expressing T cells. Immunol Rev 257:107-26
Hegde, Meenakshi; Corder, Amanda; Chow, Kevin K H et al. (2013) Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma. Mol Ther 21:2087-101
Doherty, Joseph E; Woodard, Lauren E; Bear, Adham S et al. (2013) An adaptable system for improving transposon-based gene expression in vivo via transient transgene repression. FASEB J 27:3753-62
Brenner, Malcolm K; Gottschalk, Stephen; Leen, Ann M et al. (2013) Is cancer gene therapy an empty suit? Lancet Oncol 14:e447-e456
Doherty, Joseph E; Huye, Leslie E; Yusa, Kosuke et al. (2012) Hyperactive piggyBac gene transfer in human cells and in vivo. Hum Gene Ther 23:311-20
Kettlun, Claudia; Galvan, Daniel L; George Jr, Alfred L et al. (2011) Manipulating piggyBac transposon chromosomal integration site selection in human cells. Mol Ther 19:1636-44

Showing the most recent 10 out of 24 publications